Kingianins O-Q: Pentacyclic polyketides from Endiandra kingiana as inhibitor of Mcl-1/Bid interaction

被引:20
作者
Azmi, Mohamad Nurul [1 ]
Peresse, Tiphaine [2 ]
Remeur, Camille [2 ]
Chan, Gomathi [1 ]
Roussi, Fanny [2 ]
Litaudon, Marc [2 ]
Awang, Khalijah [1 ]
机构
[1] Univ Malaya, Fac Sci, Dept Chem, Ctr Nat Prod Res & Drug Discovery CENAR, Kuala Lumpur 50603, Malaysia
[2] Univ Paris 11, CNRS, UPR2301, ICSN, Av Terrasse, F-91198 Gif Sur Yvette, France
关键词
Endiandra kingiana; Kingianins; Lauraceae; Anti-apoptotic protein; Mcl-1/Bid; CANCER; ANTAGONISTS; FAMILY;
D O I
10.1016/j.fitote.2016.01.004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A phytochemical study of the EtOAc-soluble part of the methanolic extract of the bark of Endiandra kingiana led to the isolation of three new pentacyclic kingianins as racemic mixtures, kingianins O-Q (1-3), together with the known kingianins A, F, K, L, M and N (4-9), respectively. The structures of the new kingianins 1-3 were determined by 1D and 2D NMR analysis in combination with HRESIMS experiments. Kingianins A-Qwere assayed for Mcl-1 binding affinity. Kingianins G and H were found to be potent inhibitors of Mc1-1/Bid interaction. A structure-activity relationship study showed that potency is very sensitive to the substitution pattern on the pentacyclic core. In addition, in contrast with the binding affinity for Bcl-xL, the levorotatory enantiomers of kingianins G, 'H and J exhibited similar binding affinities for Mcl-1 than their dextrorotatory counterparts, indicating that the two anti-apoptotic proteins have slightly different binding profiles. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 17 条
[1]   Kingianic Acids A-G, Endiandric Acid Analogues from Endiandra kingiana [J].
Azmi, Mohamad Nurul ;
Geny, Charlotte ;
Leverrier, Aurelie ;
Litaudon, Marc ;
Dumontet, Vincent ;
Birlirakis, Nicolas ;
Gueritte, Francoise ;
Leong, Kok Hoong ;
Abd Halim, Siti Nadiah ;
Mohamad, Khalit ;
Awang, Khalijah .
MOLECULES, 2014, 19 (02) :1732-1747
[2]  
Burkill I. H., 1966, NATURE
[3]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[4]   Targeted therapies in gynecologic cancers [J].
Chon, Hye Sook ;
Hu, Wei ;
Kavanagh, John J. .
CURRENT CANCER DRUG TARGETS, 2006, 6 (04) :333-363
[5]   Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer [J].
Davids, Matthew S. ;
Letai, Anthony .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) :3127-3135
[6]   CANCER THERAPEUTICS Pulling the plug on BCL-XL [J].
Jeng, Paul S. ;
Cheng, Emily H. .
NATURE CHEMICAL BIOLOGY, 2013, 9 (06) :351-352
[7]   Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy [J].
Kang, Min H. ;
Reynolds, C. Patrick .
CLINICAL CANCER RESEARCH, 2009, 15 (04) :1126-1132
[8]   BCL-2 family antagonists for cancer therapy [J].
Lessene, Guillaume ;
Czabotar, Peter E. ;
Colman, Peter M. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) :989-1000
[9]   Pentacyclic polyketides from Endiandra kingiana as inhibitors of the Bcl-xL/Bak interaction [J].
Leverrier, Aurelie ;
Awang, Khalijah ;
Gueritte, Francoise ;
Litaudon, Marc .
PHYTOCHEMISTRY, 2011, 72 (11-12) :1443-1452
[10]   Kingianin A: A New Natural Pentacyclic Compound from Endiandra kingiana [J].
Leverrier, Aurelie ;
Dau, Marie Elise Tran Huu ;
Retailleau, Pascal ;
Awang, Khalijah ;
Gueritte, Francoise ;
Litaudon, Marc .
ORGANIC LETTERS, 2010, 12 (16) :3638-3641